Incyte (INCY) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free INCY Stock Alerts $52.09 -0.47 (-0.89%) (As of 10:34 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIncyte misses quarterly profit on weak sales of lead drugreuters.com - April 30 at 10:25 AMIncyte Corp (INCY) Q1 2024 Earnings: Misses Revenue Estimates but Shows Strong Growth in ...finance.yahoo.com - April 30 at 10:17 AMIncyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programsbusinesswire.com - April 30 at 7:00 AMWhat Wall Street expects from Incyte's earningsmarkets.businessinsider.com - April 30 at 1:19 AMTruist Financial Reaffirms Their Buy Rating on Incyte (INCY)markets.businessinsider.com - April 29 at 3:06 PMRussell Investments Group Ltd. Raises Holdings in Incyte Co. (NASDAQ:INCY)marketbeat.com - April 29 at 7:24 AMIncyte (NASDAQ:INCY) Price Target Cut to $84.00 by Analysts at Oppenheimeramericanbankingnews.com - April 28 at 7:10 AMIncyte Co. (NASDAQ:INCY) Shares Sold by Sector Gamma ASmarketbeat.com - April 27 at 4:38 PMIncyte Pharmaceuticals: Cheap Enough Now (Rating Upgrade)seekingalpha.com - April 26 at 1:45 PMHandelsbanken Fonder AB Has $6.39 Million Stock Position in Incyte Co. (NASDAQ:INCY)marketbeat.com - April 26 at 6:39 AMQ1 2025 Earnings Forecast for Incyte Co. (NASDAQ:INCY) Issued By William Blairamericanbankingnews.com - April 26 at 3:16 AMWilliam Blair Analysts Raise Earnings Estimates for Incyte Co. (NASDAQ:INCY)marketbeat.com - April 25 at 8:47 AMIncyte Co. (NASDAQ:INCY) to Post Q2 2025 Earnings of $1.19 Per Share, William Blair Forecastsamericanbankingnews.com - April 25 at 2:36 AMAlaska Permanent Fund Corp Sells 25,830 Shares of Incyte Co. (NASDAQ:INCY)marketbeat.com - April 24 at 5:16 PMIncyte (NASDAQ:INCY) Price Target Lowered to $84.00 at Oppenheimermarketbeat.com - April 24 at 8:28 AMIncyte Co. Forecasted to Post Q2 2025 Earnings of $1.19 Per Share (NASDAQ:INCY)marketbeat.com - April 24 at 6:49 AMIncyte (NASDAQ:INCY) Now Covered by Analysts at Cantor Fitzgeraldamericanbankingnews.com - April 24 at 4:44 AMPeeling Back The Layers: Exploring Incyte Through Analyst Insightsmarkets.businessinsider.com - April 23 at 4:41 PMIncyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommendsmarkets.businessinsider.com - April 23 at 4:41 PMIncyte to Buy Escient Pharmaceuticals for $750 Millionmarketwatch.com - April 23 at 11:39 AMIncyte To Buy Privately Held Escient Pharmamarkets.businessinsider.com - April 23 at 11:39 AMIncyte to acquire San Diego pharma firm in $750 million dealbizjournals.com - April 23 at 11:39 AMIncyte (NASDAQ:INCY) Coverage Initiated by Analysts at Cantor Fitzgeraldmarketbeat.com - April 23 at 7:15 AMIncyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonistsbusinesswire.com - April 23 at 7:00 AMIncyte (INCY) Scheduled to Post Earnings on Tuesdayamericanbankingnews.com - April 23 at 5:36 AMFederated Hermes Inc. Raises Stock Position in Incyte Co. (NASDAQ:INCY)marketbeat.com - April 20 at 7:16 AMQ1 2024 EPS Estimates for Incyte Co. Increased by William Blair (NASDAQ:INCY)americanbankingnews.com - April 20 at 1:32 AMQ1 2024 EPS Estimates for Incyte Co. (NASDAQ:INCY) Lifted by William Blairmarketbeat.com - April 19 at 8:17 AMZurcher Kantonalbank Zurich Cantonalbank Raises Stock Holdings in Incyte Co. (NASDAQ:INCY)marketbeat.com - April 18 at 7:48 AMIncyte (NASDAQ:INCY) Sees Unusually-High Trading Volumemarketbeat.com - April 17 at 11:37 AMCornercap Investment Counsel Inc. Takes $995,000 Position in Incyte Co. (NASDAQ:INCY)marketbeat.com - April 16 at 8:27 AMThe past three years for Incyte (NASDAQ:INCY) investors has not been profitablefinance.yahoo.com - April 15 at 9:47 AMAllspring Global Investments Holdings LLC Purchases 259,779 Shares of Incyte Co. (NASDAQ:INCY)marketbeat.com - April 12 at 6:18 AMIncyte to Report First Quarter Financial Resultsbusinesswire.com - April 11 at 8:00 AMPublic Markets Are the New Private Marketsbloomberg.com - April 9 at 3:58 PMBay Area exec loses groundbreaking 'shadow trading' trialmsn.com - April 9 at 3:58 PMIncyte Co. (NASDAQ:INCY) Shares Sold by Grimes & Company Inc.marketbeat.com - April 7 at 9:11 AMBiotech Executive Who Bet on Rival’s Stock Committed Insider Trading, Jury Saysfinance.yahoo.com - April 6 at 1:40 PMIncyte Co. (NASDAQ:INCY) Shares Sold by Legacy Trustmarketbeat.com - April 5 at 6:23 PMIncyte Co. (NASDAQ:INCY) Shares Bought by China Universal Asset Management Co. Ltd.marketbeat.com - April 4 at 6:54 PMCMS To Receive License To Develop, Commercialize Povorcitinib In China And Southeast Asiamarkets.businessinsider.com - April 1 at 9:31 AMIncyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asiafinance.yahoo.com - April 1 at 9:31 AMCMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asiaglobenewswire.com - April 1 at 8:30 AMIncyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 29 at 4:30 PMARK Investment Management LLC Boosts Stock Holdings in Incyte Co. (NASDAQ:INCY)marketbeat.com - March 28 at 6:39 AMJGP Global Gestao de Recursos Ltda. Has $1.97 Million Position in Incyte Co. (NASDAQ:INCY)marketbeat.com - March 27 at 12:34 PMAssenagon Asset Management S.A. Has $39.85 Million Holdings in Incyte Co. (NASDAQ:INCY)marketbeat.com - March 26 at 2:58 PMSEC Tests Insider-Trading Theory at Trial of Ex-Biotech Executivefinance.yahoo.com - March 26 at 12:56 AMRoyal Bank of Canada Reiterates "Sector Perform" Rating for Incyte (NASDAQ:INCY)marketbeat.com - March 25 at 12:19 PMJean-Jacques Bienaimé Appointed Chairman of the Board at Owkinfinance.yahoo.com - March 25 at 8:28 AM Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne’s Gift to Stock Investors (Ad)Right now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too. Watch Insider's Advantage Event Tuesday at 4:00 PM ET INCY Media Mentions By Week INCY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼0.320.34▲Average Medical News Sentiment INCY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼308▲INCY Articles Average Week Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Charles River Laboratories International News Today Medpace News Today Exelixis News Today National Research News Today ICON Public News Today IQVIA News Today Exact Sciences News Today Insulet News Today DaVita News Today Dr. Reddy's Laboratories News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityProtect Your Bank Account Before It’s Too LateWeiss RatingsWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
